{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:22:27Z","timestamp":1785817347794,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.prostaglandins.2007.05.001","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T12:54:55Z","timestamp":1180097695000},"page":"116-127","source":"Crossref","is-referenced-by-count":32,"title":["Inhibition of VEGF expression and corneal neovascularization by siRNA targeting cytochrome P450 4B1"],"prefix":"10.1016","volume":"84","author":[{"given":"Francesca","family":"Seta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mezentsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowena","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal Laniado","family":"Schwartzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2007.05.001_bib1","series-title":"Cytochrome P450 and arachidonic acid metabolism in the corneal epithelium: role in inflammation","author":"Schwartzman","year":"1997"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib2","first-page":"828","article-title":"A closed eye-contact lens model of corneal inflammation. I. Induction of cytochrome P450 arachidonic acid metabolism","volume":"36","author":"Conners","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib3","first-page":"1963","article-title":"Alkali burn-induced synthesis of inflammatory eicosanoids in rabbit corneal epithelium","volume":"38","author":"Conners","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib4","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0022-3565(24)37879-6","article-title":"Hypoxia stimulates the synthesis of cytochrome P450-derived inflammatory eicosanoids in rabbit corneal epithelium","volume":"287","author":"Vafeas","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib5","first-page":"841","article-title":"A closed eye-contact lens model of corneal inflammation. II. Inhibition of cytochrome P450 arachidonic acid metabolism alleviates inflammatory sequelae","volume":"36","author":"Conners","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib6","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0006-2952(97)00080-4","article-title":"Heme oxygenase induction with attenuation of experimentally-induced corneal inflammation","volume":"53","author":"Schwartzman","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib7","doi-asserted-by":"crossref","first-page":"17197","DOI":"10.1016\/S0021-9258(18)37517-3","article-title":"12(R)-hydroxyeicosatetrienoic acid: a vasodilator cytochrome P450 dependent arachidonate metabolite from bovine corneal epithelium","volume":"263","author":"Murphy","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0014-4835(91)90037-F","article-title":"12(R)-hydroxyeicosatrienoic acid, a potent chemotactic and angiogenic factor produced by the cornea","volume":"52","author":"Masferrer","year":"1991","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib9","first-page":"129","article-title":"Direct stimulation of limbal microvessel endothelial cell proliferation and capillary formation in vitro by a corneal- derived eicosanoid","volume":"148","author":"Stoltz","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib10","first-page":"328","article-title":"Detection of endogenous 12-hydroxyeicosatrienoic acid in human tear film","volume":"42","author":"Mieyal","year":"2001","journal-title":"Invest Ophthalmol"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib11","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0022-3565(24)38312-0","article-title":"Hypoxia-Induced Production of 12- Hydroxyeicosanoids in the Corneal Epithelium: involvement of a CYP4B1 Isoform","volume":"289","author":"Mastyugin","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib12","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/jcb.20018","article-title":"Promoter activity and regulation of the corneal CYP4B1 gene by hypoxia","volume":"15","author":"Mastyugin","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1076\/ceyr.23.1.1.5422","article-title":"Corneal epithelial VEGF and cytochrome P450 4B1 expression in a rabbit model of closed eye contact lens wear","volume":"23","author":"Mastyugin","year":"2001","journal-title":"Curr Eye Res"},{"issue":"5","key":"10.1016\/j.prostaglandins.2007.05.001_bib14","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2353\/ajpath.2006.060555","article-title":"Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response","volume":"169","author":"Seta","year":"2006","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.prostaglandins.2007.05.001_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1124\/jpet.105.088211","article-title":"Transfection of cytochrome P4504B1 into the cornea increases angiogenic activity of the limbal vessels","volume":"315","author":"Mezentsev","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.prostaglandins.2007.05.001_bib16","first-page":"413","article-title":"Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas","volume":"37","author":"Streilein","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.prostaglandins.2007.05.001_bib17","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","volume":"113","author":"Cursiefen","year":"2004","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.prostaglandins.2007.05.001_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.exer.2004.08.023","article-title":"Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice","volume":"80","author":"Samolov","year":"2005","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.prostaglandins.2007.05.001_bib19","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1167\/iovs.02-0572","article-title":"Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization","volume":"44","author":"Holzer","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib20","first-page":"2665","article-title":"Immortalization of rabbit corneal epithelial cells by a recombinant SV40-adenovirus vector","volume":"34","author":"Araki","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib21","first-page":"2170","article-title":"The effect of hypoxia on endogenous corneal epithelial eicosanoids","volume":"41","author":"Mieyal","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib22","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1016\/S0040-4039(00)99285-2","article-title":"Synthesis and structure of compound D, a pro-inflammatory arachidonate metabolite","volume":"30","author":"Shin","year":"1989","journal-title":"Tetrahedron Lett"},{"issue":"9","key":"10.1016\/j.prostaglandins.2007.05.001_bib23","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib24","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.105.088211","article-title":"Transfection of Cyp4b1 into the cornea increases angiogenic activity of the limbal vessels","author":"Mezentsev","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"21","key":"10.1016\/j.prostaglandins.2007.05.001_bib25","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1074\/jbc.M201143200","article-title":"Eicosanoid regulation of vascular endothelial growth factor expression and angiogenesis in microvessel endothelial cells","volume":"277","author":"Mezentsev","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib26","first-page":"210","article-title":"Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model","volume":"9","author":"Reich","year":"2003","journal-title":"Mol Vis"},{"issue":"6","key":"10.1016\/j.prostaglandins.2007.05.001_bib27","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0002-9440(10)63267-1","article-title":"Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis","volume":"165","author":"Kim","year":"2004","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.prostaglandins.2007.05.001_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.gt.3302641","article-title":"Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1","volume":"13","author":"Shen","year":"2006","journal-title":"Gene Ther"},{"issue":"2","key":"10.1016\/j.prostaglandins.2007.05.001_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02713680500514636","article-title":"Inhibition of ocular angiogenesis by diced small interfering RNAs (siRNAs) specific to vascular endothelial growth factor (VEGF)","volume":"31","author":"Murata","year":"2006","journal-title":"Curr Eye Res"},{"issue":"2","key":"10.1016\/j.prostaglandins.2007.05.001_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0002-9440(10)62282-1","article-title":"Inhibitors of cytochrome P450 4A suppress angiogenic responses","volume":"166","author":"Chen","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib31","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization","volume":"39","author":"Amano","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.prostaglandins.2007.05.001_bib32","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas [In Process Citation]","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.prostaglandins.2007.05.001_bib33","first-page":"1975","article-title":"Rapid ocular angiogenic control via naked DNA delivery to cornea","volume":"42","author":"Stechschulte","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.prostaglandins.2007.05.001_bib34","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1089\/104303401750270959","article-title":"Inhibition of angiogenesis by adenovirus- mediated sFlt-1 expression in a rat model of corneal neovascularization","volume":"12","author":"Lai","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"4","key":"10.1016\/j.prostaglandins.2007.05.001_bib35","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0002-9440(10)64643-3","article-title":"CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury","volume":"157","author":"Moromizato","year":"2000","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.prostaglandins.2007.05.001_bib36","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1167\/iovs.03-0106","article-title":"VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2","volume":"45","author":"Usui","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib37","doi-asserted-by":"crossref","first-page":"10126","DOI":"10.1021\/bi00495a017","article-title":"Metabolism of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid and other hydroxylated fatty acids by the reductase pathway in porcine polymorphonuclear leukocytes","volume":"29","author":"Wainwright","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","article-title":"Vascular endothelial growth factors and angiogenesis in eye disease","volume":"22","author":"Witmer","year":"2003","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib39","first-page":"1464","article-title":"Presence of heme oxygensae and NADPH cytochrome P450 (c) reductase in human corneal epithelium","volume":"28","author":"Abraham","year":"1987","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib40","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1476-5381.1988.tb11620.x","article-title":"Psoriatic skin lesions contain a novel lipid neutrophil chemokinetic compound which is distinct from known chemoattractant compounds","volume":"94","author":"Camp","year":"1988","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.prostaglandins.2007.05.001_bib41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1124\/jpet.105.093922","article-title":"A biosynthetic pathway generating 12-hydroxy-5,8,14-eicosatrienoic acid from arachidonic acid is active in mouse skin microsomes","volume":"316","author":"Du","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib42","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0003-9861(91)90548-W","article-title":"Metabolism of 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid (12(R)-HETE) in corneal tissues: formation of novel metabolites","volume":"290","author":"Nishimura","year":"1991","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.prostaglandins.2007.05.001_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0005-2760(94)90124-4","article-title":"Oxidation and keto reduction of 12-hydroxy-5,8,10,14-eicosatetraenoic acids in bovine corneal epithelial microsomes","volume":"1210","author":"Yamamoto","year":"1994","journal-title":"Biochim Biophys Acta"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882307000810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882307000810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T17:57:56Z","timestamp":1737050276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882307000810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":43,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S1098882307000810"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2007.05.001","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}